NORDIC BIOSITE ApS: Financial statements 2019
CVR: 30711572
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NORDIC BIOSITE ApS (CVR 30711572) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 3,098,374 and a net result of DKK 1,283,800 compared with DKK 944,861 the year before. That is an increase of 4.9% compared with the year before. Equity in the 2019 report amounted to DKK 1,416,683. The solvency ratio was 40.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 3,098,374
- Profit/Loss
- DKK 1,283,800
- Equity
- DKK 1,416,683
- Total Assets
- DKK 3,472,693
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 3.1 mio. | 1.3 mio. | 1.4 mio. | 2 |
| 2018 | - | 3 mio. | 945 t. | 1.1 mio. | 3 |
| 2017 | 18 mio. | 2.5 mio. | 880 t. | 1.1 mio. | 2 |
| 2016 | - | 2.3 mio. | 546 t. | 1.2 mio. | 3 |
| 2015 | - | 2 mio. | 276 t. | 662 t. | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NORDIC BIOSITE ApS has published its annual report for 2018. Gross profit came to DKK 2,952,821, and the net result was DKK 944,861.
About NORDIC BIOSITE ApS
NORDIC BIOSITE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2007. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The management consists of Rasmus Valdemar Lind. The board consists of Rasmus Valdemar Lind (chair) and Claudia Maria Carolina Berron Osorno. The company is owned by Nordic Biosite AB. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 6,639,125 and a net result of DKK 1,220,258 compared with DKK 1,205,660 the year before. Equity in the 2025 report amounted to DKK 1,808,346.